 Compared With Sulfonylurea For Patients With Type 2 Diabetes<br />
<b>Deprecated</b>: urlencode(): Passing null to parameter #1 ($string) of type string is deprecated in <b>/var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php</b> on line <b>22</b><br />
)
Merck (NYSE: MRK), known as MSD outside the United States and Canada, has announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA®
Read more
JANUVIA (Sitagliptin) Compared With Sulfonylurea For Patients With Type 2 Diabetes
Posted in Drugs